{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:02:08Z","timestamp":1777525328957,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T00:00:00Z","timestamp":1507593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00330-017-5071-x","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T03:20:42Z","timestamp":1507605642000},"page":"1187-1193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Whole body magnetic resonance in indolent lymphomas under watchful waiting: The time is now"],"prefix":"10.1007","volume":"28","author":[{"given":"Massimo","family":"Galia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7989-9861","authenticated-orcid":false,"given":"Domenico","family":"Albano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrado","family":"Tarella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Patti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca Maria","family":"Sconfienza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonino","family":"Mul\u00e8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierpaolo","family":"Alongi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Midiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Lagalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,10]]},"reference":[{"key":"5071_CR1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.blre.2012.09.004","volume":"26","author":"M Lunning","year":"2012","unstructured":"Lunning M, Vose JM (2012) Management of indolent lymphoma: Where are we now and where are we going. Blood Rev 26:279\u2013288","journal-title":"Blood Rev"},{"key":"5071_CR2","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1182\/blood-2015-11-632745","volume":"127","author":"JO Armitage","year":"2016","unstructured":"Armitage JO, Longo DL (2016) Is watch and wait still acceptable for patients with low-grade follicular lymphoma? Blood 127:2804\u20132808","journal-title":"Blood"},{"key":"5071_CR3","doi-asserted-by":"crossref","unstructured":"Sorigue M, Sancho JM, Ribera JM (2016) Open questions in watchful waiting for follicular lymphoma. Br J Haematol (in press)","DOI":"10.1111\/bjh.14246"},{"key":"5071_CR4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/ajh.23372","volume":"88","author":"PL Zinzani","year":"2013","unstructured":"Zinzani PL, Marchetti M, Billio A et al (2013) Expert Panel of the Italian Society of Hematology. SIE, SIES, GITMO revised guidelines for the management of follicular lymphoma. Am J Hematol 88:185\u2013192","journal-title":"Am J Hematol"},{"key":"5071_CR5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.clml.2014.07.002","volume":"15","author":"C Tarella","year":"2015","unstructured":"Tarella C, Arcaini L, Baldini L et al (2015) Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation guidelines for the management of indolent, nonfollicular B-cell lymphoma (marginal zone, lymphoplasmacytic, and small lymphocytic lymphoma). Clin Lymphoma Myeloma Leuk 15:75\u201385","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"5071_CR6","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1182\/blood-2005-11-4659","volume":"107","author":"L Arcaini","year":"2006","unstructured":"Arcaini L, Lazzarino M, Colombo N et al (2006) Splenic marginal zone lymphoma: a prognostic model for clinical use. Blood 107:4643\u20134649","journal-title":"Blood"},{"key":"5071_CR7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sj.leu.2405068","volume":"22","author":"E Matutes","year":"2008","unstructured":"Matutes E, Oscier D, Montalban C et al (2008) Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria. Leukemia 22:487\u2013495","journal-title":"Leukemia"},{"key":"5071_CR8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3322\/caac.21330","volume":"66","author":"M Raderer","year":"2016","unstructured":"Raderer M, Kiesewetter B, Ferreri AJ (2016) Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). CA Cancer J Clin 66:153\u2013171","journal-title":"CA Cancer J Clin"},{"key":"5071_CR9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/annonc\/mdj025","volume":"17","author":"K Tanimoto","year":"2006","unstructured":"Tanimoto K, Kaneko A, Suzuki S et al (2006) Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma. Ann Oncol 17:135\u2013140","journal-title":"Ann Oncol"},{"key":"5071_CR10","first-page":"3633","volume":"27","author":"M Troch","year":"2007","unstructured":"Troch M, Streubel B, Petkov V, Turetschek K, Chott A, Raderer M (2007) Does MALT lymphoma of the lung require immediate treatment? An analysis of 11 untreated cases with long-term follow-up. Anticancer Res 27:3633\u20133637","journal-title":"Anticancer Res"},{"key":"5071_CR11","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0140-6736(03)14110-4","volume":"362","author":"KM Ardeshna","year":"2003","unstructured":"Ardeshna KM, Smith P, Norton A et al (2003) Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial. Lancet 362:516\u2013522","journal-title":"Lancet"},{"key":"5071_CR12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.blre.2011.09.002","volume":"26","author":"T Tadmor","year":"2012","unstructured":"Tadmor T, Polliack A (2012) Optimal management of older patients with chronic lymphocytic leukemia: some facts and principles guiding therapeutic choices. Blood Rev 26:15\u201323","journal-title":"Blood Rev"},{"key":"5071_CR13","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1200\/JCO.2008.19.6121","volume":"27","author":"P Martin","year":"2009","unstructured":"Martin P, Chadburn A, Christos P et al (2009) Outcome of deferred initial therapy in mantle-cell lymphoma. J Clin Oncol 27:1209\u20131213","journal-title":"J Clin Oncol"},{"key":"5071_CR14","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1038\/leu.2014.171","volume":"28","author":"M Dreyling","year":"2014","unstructured":"Dreyling M, Ferrero S, Hermine O (2014) How to manage mantle cell lymphoma. Leukemia 28:2117\u20132130","journal-title":"Leukemia"},{"key":"5071_CR15","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF et al (2014) Recommendations for initial evaluation, staging and response assessment of Hodgkin and non-Hodgkin lymphoma: the lugano classification. J Clin Oncol 32:3059\u20133067","journal-title":"J Clin Oncol"},{"key":"5071_CR16","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2016-05-718528","volume":"128","author":"BD Cheson","year":"2016","unstructured":"Cheson BD, Ansell S, Schwartz L et al (2016) Refinement of the Lugano classification response criteria for lymphoma in the era of immunomodulatory therapy. Blood 128:2489\u20132496","journal-title":"Blood"},{"key":"5071_CR17","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMra072149","volume":"357","author":"DJ Brenner","year":"2007","unstructured":"Brenner DJ, Hall EJ (2007) Computed tomography: an increasing source of radiation exposure. N Engl J Med 357:2277\u20132284","journal-title":"N Engl J Med"},{"key":"5071_CR18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3816\/CLML.2010.n.056","volume":"10","author":"P Shenoy","year":"2010","unstructured":"Shenoy P, Sinha R, Tumeh JW, Lechowicz MJ, Flowers CR (2010) Surveillance computed tomography scans for patients with lymphoma: is the risk worth the benefits? Clin. Lymphoma Myeloma Leuk 10:270\u2013277","journal-title":"Lymphoma Myeloma Leuk"},{"key":"5071_CR19","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/ijc.29433","volume":"137","author":"SH Chien","year":"2015","unstructured":"Chien SH, Liu CJ, Hu YW et al (2015) Frequency of surveillance computed tomography in non-Hodgkin lymphoma and the risk of secondary primary malignancies: a nationwide population-based study. Int J Cancer 137:658\u2013665","journal-title":"Int J Cancer"},{"key":"5071_CR20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1148\/radiol.2511081300","volume":"251","author":"B Huang","year":"2009","unstructured":"Huang B, Law MW, Khong PL (2009) Whole-body PET\/CT scanning: estimation ofradiation dose and cancer risk. Radiology 251:166\u2013174","journal-title":"Radiology"},{"key":"5071_CR21","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1093\/annonc\/mdt137","volume":"24","author":"S Luminari","year":"2013","unstructured":"Luminari S, Biasoli I, Arcaini L et al (2013) The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi. Ann Oncol 24:2108\u20132112","journal-title":"Ann Oncol"},{"key":"5071_CR22","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1182\/blood-2014-11-537522","volume":"125","author":"SD Smith","year":"2015","unstructured":"Smith SD, Redman M, Dunleavy K (2015) FDG PET-CT in follicular lymphoma: a case-based evidence review. Blood 125:1078\u20131082","journal-title":"Blood"},{"key":"5071_CR23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.beha.2011.02.006","volume":"24","author":"IS Lossos","year":"2011","unstructured":"Lossos IS, Gascoyne RD (2011) Transformation of follicular lymphoma. Best Pract Res Clin Haematol 24:147\u2013163","journal-title":"Best Pract Res Clin Haematol"},{"key":"5071_CR24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ejrad.2015.12.006","volume":"85","author":"D Albano","year":"2016","unstructured":"Albano D, Patti C, La Grutta L et al (2016) Comparison between whole-body MRI with diffusion-weighted imaging and PET\/CT in staging newly diagnosed FDG-avid lymphomas. Eur J Radiol 85:313\u2013318","journal-title":"Eur J Radiol"},{"key":"5071_CR25","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1158\/1078-0432.CCR-14-2454","volume":"21","author":"ME Mayerhoefer","year":"2015","unstructured":"Mayerhoefer ME, Karanikas G, Kletter K et al (2015) Evaluation of diffusion-weighted magnetic resonance imaging for follow-up and treatment response assessment of lymphoma: results of an 18F-FDG-PET\/CT\u2013controlled prospective study in 64 patients. Clin Cancer Res 21:2506\u20132513","journal-title":"Clin Cancer Res"},{"key":"5071_CR26","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s00330-010-1758-y","volume":"20","author":"C Lin","year":"2010","unstructured":"Lin C, Luciani A, Itti E et al (2010) Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma. Eur Radiol 20:2027\u20132038","journal-title":"Eur Radiol"},{"key":"5071_CR27","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00330-014-3114-0","volume":"24","author":"AS Littooij","year":"2014","unstructured":"Littooij AS, Kwee TC, Barber I et al (2014) Whole-body MRI for initial staging of paediatric lymphoma: prospective comparison to an FDG-PET\/CT-based reference standard. Eur Radiol 24:1153\u20131165","journal-title":"Eur Radiol"},{"key":"5071_CR28","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.mri.2016.04.023","volume":"34","author":"D Albano","year":"2016","unstructured":"Albano D, La Grutta L, Grassedonio E et al (2016) Pitfalls in whole body MRI with diffusion weighted imaging performed on patients with lymphoma: what radiologists should know. Magn Reson Imaging 34:922\u2013931","journal-title":"Magn Reson Imaging"},{"key":"5071_CR29","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1148\/radiol.2451061804","volume":"245","author":"AD King","year":"2007","unstructured":"King AD, Ahuja AT, Yeung DK et al (2007) Malignant cervical lymphadenopathy: Diagnostic accuracy of diffusion-weighted MR imaging. Radiology 245:806\u2013813","journal-title":"Radiology"},{"key":"5071_CR30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/jmri.24356","volume":"40","author":"TC Kwee","year":"2013","unstructured":"Kwee TC, Vermoolen MA, Akkerman EA et al (2013) Whole-body MRI, including diffusion-weighted imaging, for staging lymphoma: Comparison with CT in a prospective multicenter study. J Magn Reson Imaging 40:26\u201336","journal-title":"J Magn Reson Imaging"},{"key":"5071_CR31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.crad.2015.11.018","volume":"71","author":"A Balbo-Mussetto","year":"2016","unstructured":"Balbo-Mussetto A, Cirillo S, Bruna R et al (2016) Whole-body MRI with diffusion-weighted imaging: A valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma. Clinical Radiology 71:271\u2013279","journal-title":"Clinical Radiology"},{"key":"5071_CR32","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1007\/s00330-013-2835-9","volume":"23","author":"HJ Adams","year":"2013","unstructured":"Adams HJ, Kwee TC, Vermoolen MA et al (2013) Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospective study in 116 patients and comparison with FDG-PET. Eur Radiol 23:2271\u20132278","journal-title":"Eur Radiol"},{"key":"5071_CR33","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/jmri.25439","volume":"45","author":"D Albano","year":"2017","unstructured":"Albano D, Patti C, Lagalla R, Midiri M, Galia M (2017) Whole-body MRI, FDG-PET\/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma. J Magn Reson Imaging 45:1082\u20131089","journal-title":"J Magn Reson Imaging"},{"key":"5071_CR34","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1182\/blood-2010-09-271437","volume":"117","author":"E Iannitto","year":"2011","unstructured":"Iannitto E, Tripodo C (2011) How I diagnose and treat splenic lymphomas. Blood 117:2585\u20132595","journal-title":"Blood"},{"key":"5071_CR35","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/ajh.24094","volume":"90","author":"JM Vose","year":"2015","unstructured":"Vose JM (2015) Mantle cell lymphoma: 2015 update on diagnosis, risk stratification, and clinical management. Am J Hematol 90:739\u2013745","journal-title":"Am J Hematol"},{"key":"5071_CR36","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1182\/blood-2015-06-649905","volume":"126","author":"R Kridel","year":"2015","unstructured":"Kridel R, Mottok A, Farinha P et al (2015) Cell of origin of transformed follicular lymphoma. Blood 126:2118\u20132127","journal-title":"Blood"},{"key":"5071_CR37","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1007\/s00330-016-4535-8","volume":"27","author":"D Albano","year":"2017","unstructured":"Albano D, Patti C, La Grutta L et al (2017) Osteonecrosis detected by whole body magnetic resonance in patients with Hodgkin lymphoma treated by BEACOPP. Eur Radiol 27:2129\u20132136","journal-title":"Eur Radiol"},{"key":"5071_CR38","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/bjh.14452","volume":"176","author":"AS Littooij","year":"2017","unstructured":"Littooij AS, Kwee TC, Goya E et al (2017) Whole-body MRI reveals high incidence of osteonecrosis in children treated for Hodgkin lymphoma. Br J Haematol 176:637\u2013642","journal-title":"Br J Haematol"},{"key":"5071_CR39","doi-asserted-by":"crossref","first-page":"20170240","DOI":"10.1259\/bjr.20170280","volume":"190","author":"D Albano","year":"2017","unstructured":"Albano D, Patti C, Sconfienza LM, Galia M (2017) Whole-body MRI in the early detection of multifocal osteonecrosis. Br J Radiol 190:20170240","journal-title":"Br J Radiol"},{"key":"5071_CR40","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s00330-015-3945-3","volume":"26","author":"C Messina","year":"2016","unstructured":"Messina C, Banfi G, Aliprandi A et al (2016) Ultrasound guidance to perform intra-articular injection of gadolinium-based contrast material for magnetic resonance arthrography as an alternative to fluoroscopy: the time is now. Eur Radiol 26:1221\u20131225","journal-title":"Eur Radiol"},{"key":"5071_CR41","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.acra.2016.01.012","volume":"23","author":"X Wu","year":"2016","unstructured":"Wu X, Siki\u00f6 M, Pertovaara H et al (2016) Differentiation of diffuse large B-cell lymphoma from follicular lymphoma using texture analysis on conventional MR images at 3.0 Tesla. Acad Radiol 23:696\u2013703","journal-title":"Acad Radiol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-017-5071-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-017-5071-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-017-5071-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T07:40:30Z","timestamp":1570174830000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-017-5071-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,10]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["5071"],"URL":"https:\/\/doi.org\/10.1007\/s00330-017-5071-x","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,10]]}}}